Roles > radioactive imaging agent
Page last updated: 2024-08-05 15:48:33
radioactive imaging agent
null
ChEBI ID: 37336
Members (3)
| Member | Definition | Class |
|---|
| bay94 9172 | A member of the class of stilbenoids in which the para-hydrogens of stilbene are replaced by methylamino and 2-{2-[2-((18)F)fluoroethoxy]ethoxy}ethoxy) groups. A positron emission tomography imaging ligand for the detection of amyloid aggregation associated with Alzheimer disease. | florbetaben ((18)F) |
| florbetapir f 18 | An aromatic ether consisting of a pyridine ring substituted at position 2 by a 2-{2-[2-((18)F)fluoroethoxy]ethoxy}ethoxy group and at position 5 and a 2-(4-methylaminophenyl)vinyl group. A positron emission tomography imaging ligand for the detection of amyloid aggregation associated with Alzheimer disease. | florbetapir F-18 |
| vizamyl | A member of the class of benzothiazoles that is 1,3-benzothiazole substituted by 3-((18)F)fluoro-4-(methylamino)phenyl and hydroxy groups at positions 3 and 6 respectively. A positron emission tomography imaging ligand for the detection of amyloid aggregation associated with Alzheimer disease. | flutemetamol ((18)F) |
Research
Studies (351)
| Timeframe | Studies, Drugs with This Role(%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (0.57) | 29.6817 |
| 2010's | 279 (79.49) | 24.3611 |
| 2020's | 70 (19.94) | 2.80 |
Study Types
| Publication Type | Studies, Drugs with this Role (%) | All Drugs (%) |
|---|
| Trials | 24 (6.32%) | 5.53% |
| Reviews | 19 (5.00%) | 6.00% |
| Case Studies | 22 (5.79%) | 4.05% |
| Observational | 4 (1.05%) | 0.25% |
| Other | 311 (81.84%) | 84.16% |
Protein Targets (1)
Inhibition Measurements